Vanhaleweyk, G.L.J.

flecainide patient heart rate nisoldipine effect heart pressure fraction wall motion administration motion volume increase segment value minute ejection fraction plasma flecainide levels measurement marker artery disease change level relaxation 15 minutes ejection artery blood end-diastolic table decrease study function oxygen hemodynamic oxygen consumption plasma treatment sinus <10 disease index dp /dt infusion end-systolic isovolumic resistance cref values american journal aortic pressure flecainide acetate serruy systolic result dimension 40 ms consumption end-diastolic pressure hemodynamic effects flecainide administration blood flow 1 marker pair analysis interval 2 mg /kg sinus blood flow lv end-diastolic pressure plasma flecainide level baseline marker separation flecainide dose stroke volume aortic epicardial radiopaque markers mm hg drug res 200 mg reiber jhc acetate